Literature DB >> 30690877

New entities, new technologies, new findings: A review of the cytologic features of recently established subtypes of renal cell carcinoma.

Valentina Robila1, Adele O Kraft1, Steven Christopher Smith1,2.   

Abstract

Several new renal tumor types with distinctive pathologic, epidemiologic, and genetic signatures have recently been adopted in the fourth edition of the World Health Organization classification. In succeeding years, the cytologic features of most of these new types have been described, adding to the trend of increasing diagnostic accuracy for most common renal cell carcinoma subtypes and the important diagnostic role of cytologic sampling in the management and personalization of therapy. The current article reviews the cytologic findings from these recently established renal cell carcinoma subtypes. Emphasis is placed on cytologic diagnostic clues, confirmatory ancillary testing, salient differential diagnoses, and challenges that can be encountered in an attempt to render accurate interpretations in small samples.
© 2019 American Cancer Society.

Entities:  

Keywords:  acquired cystic disease-associated renal cell carcinoma; aspiration cytology; clear cell papillary renal cell carcinoma; fumarate hydratase-deficient renal cell carcinoma; microphthalmia-associated transcription factor (MiT) family translocation renal cell carcinoma; succinate dehydrogenase-deficient renal cell carcinoma; tubulocystic renal cell carcinoma

Mesh:

Year:  2019        PMID: 30690877     DOI: 10.1002/cncy.22093

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN: 1934-662X            Impact factor:   5.284


  3 in total

1.  Tubulocystic renal cell carcinoma: Two-case report and literature review.

Authors:  Siwei Xing; Ao Liu; Xiaoqun Yang; Lu Chen; Danfeng Xu
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

2.  A Reliable Prediction Model for Renal Cell Carcinoma Subtype Based on Radiomic Features from 3D Multiphase Enhanced CT Images.

Authors:  Haijie Zhang; Fu Yin; Menglin Chen; Anqi Qi; Zihao Lai; Liyang Yang; Ge Wen
Journal:  J Oncol       Date:  2021-09-21       Impact factor: 4.375

3.  Case Report: TFE3 Positive Xp11.2 Translocation Renal Cell Carcinoma (TRCC) - A Case Study and Review of the Literature.

Authors:  Ignacy Miroński; Jan Mateusz Zaucha; Jacek Kowalski; Renata Zaucha
Journal:  Front Oncol       Date:  2022-01-20       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.